Commencement of Commercial Production at Unit-II of Asston Pharmaceuticals Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals Limited has commenced commercial production at its Unit-II manufacturing facility located at MIDC, Additional Ambernath, Anand Nagar Industrial Area, Dist-Thane, Maharashtra, effective January 21, 2026. The unit manufactures pharmaceutical and nutraceutical products. This follows the company's earlier communication dated November 14, 2025 regarding capacity addition, and the company states the commissioning has happened 'as per the scheduled plan.' Unit-II is described as a new manufacturing unit being brought online.
This is a positive development as it expands the company's manufacturing capacity for pharmaceuticals and nutraceuticals, potentially enabling higher revenues and market reach. Shareholders should watch for incremental order wins and revenue contribution from Unit-II in upcoming quarterly results.